Impressum / Imprint

2cureX GmbH
(Tochtergesellschaft der 2curex AS / subsidiary of 2curex AS https://www.2curex.com/contact/)

Spectrum Building at UKE
Martinistraße 64
20251 Hamburg
Germany

Tel.: +49 173 6000 704
E-Mail: info@2curex.com

Verantwortlich für den Inhalt nach § 55 II RStV / Responsible for the content according to § 55 II RStV
Dr. Jürgen Kupper, Geschäftsführer

Vertreten durch / Represented by
Dr. Jürgen Kupper, Geschäftsführer

Gesellschafter / Shareholder
2cureX AS Vertreten durch / Represented by Prof. Ole Thastrup, Chief Executive Officer

Handelsregistereintrag / Commercial Register
HRB 137736, Amtsgericht Hamburg

Umsatzsteuer-ID-Nr. / VAT ID
DE303308758

Ausstellende Behörde / Issuing Authority
Hansestadt Hamburg

Upcoming events

October 21, 2021

Presentation by Henrik Harling (CMO 2cureX) at the 17. National Congress of Digestive Cancers (Viseu, Portugal)

Read more

November 15, 2021

Presentation by Ole Thastrup (CSO 2cureX) at the TechConnect Europe Innovation Conference & Expo (Malmø, Sweden)

Read more

November 25, 2021

Q3 2021 Interim Report released

View previous reports

February 24, 2022

Year-End Report 2021

View previous reports

IndiTreat® supports genomic characterization of tumors with unique functional information of treatment resistance and sensitivity.